Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Biopharmaceutics & Drug Disposition|December 1, 1994
Griseofulvin absorption from different sites in the human small intestineT Gramatté
British Journal of Clinical Pharmacology|June 1, 1994
Paracetamol absorption from different sites in the human small intestineT Gramatté, K Richter
Clinical Pharmacology and Therapeutics|October 8, 1999
Intestinal secretion of intravenous talinolol is inhibited by luminal R-verapamilT Gramatté, R Oertel
Biomedica Biochimica Acta|January 1, 1986
The effect of early postnatal hypoxia on the development of locomotor activity in ratsT Gramatté, J Schmidt
International Journal of Clinical Pharmacology, Therapy, and Toxicology|April 1, 1991
The variability of orocecal transit time evaluated by the salicylazosulphapyridine/sulphapyridine methodT Gramatté, B Terhaag
Deutsche Zeitschrift Fur Verdauungs- Und Stoffwechselkrankheiten|January 1, 1988
[Clinico-pharmacologic studies with a M1 receptor antagonist (substance AWD 26-06) in a phase I clinical trial]B Terhaag, T Gramatté, K Feller
European Journal of Clinical Pharmacology|January 1, 1994
Site-dependent small intestinal absorption of ranitidineT Gramatté, E el Desoky, U Klotz
Clinical Pharmacology and Therapeutics|May 1, 1996
Direct demonstration of small intestinal secretion and site-dependent absorption of the beta-blocker talinolol in humansT Gramatté, R Oertel, B Terhaag, et al.
Biopharmaceutics & Drug Disposition|July 1, 1995
Disposition and bioavailability of the beta 1-adrenoceptor antagonist talinolol in manB Trausch, R Oertel, K Richter, et al.
Pageof 4